Source: Press Release 2/21/2012

Reliv Earns Patent for GlucAffect

CHESTERFIELD, Mo., Feb. 21, 2012 - Reliv International announced that GlucAffect®, Reliv's blood sugar management supplement, has earned a patent from the US government.Dr. Carl W. Hastings, Reliv's chief scientific officer and creator of GlucAffect, made the announcement as part of opening night at Reliv's 2012 National Conference.

"Earning this patent validates the work our R&D team put into making GlucAffect a superior nutritional approach to blood sugar management," Hastings said. "GlucAffect addresses one of today's biggest health problems - metabolic syndrome - like no other product available. Most importantly, it works."

In an eight-week, placebo-controlled clinical study of 50 overweight individuals with elevated blood glucose levels, test subjects taking GlucAffect lowered their fasting blood glucose by an average of 30%, moving from elevated glucose levels to healthy blood sugar values. In addition, those individuals taking GlucAffect lost an average of nearly 16 pounds during the eight-week period. No significant glucose lowering or weight loss was found in the control group.

Elevated blood glucose levels and being overweight are key factors in metabolic syndrome, which dramatically increases the likelihood of developing diseases such as diabetes, heart disease and stroke. According to the American Heart Association, metabolic syndrome affects about 35 percent of American adults.

"Metabolic syndrome is a serious, emerging health concern among the medical community, and physicians are more frequently looking to nutrition science to complement traditional care and prescriptive remedies," Dr. Hastings said. "We see the GlucAffect study results and the success stories of GlucAffect consumers as validation of nutrition's important role."

One of GlucAffect's main active ingredients, Pycnogenol®, is an antioxidant clinically shown to help lower high blood glucose levels and provide other health benefits. Additional key ingredients in GlucAffect include omega-3 fish oils, Madeglucyl™, Glucohelp®, SilbinolÒ and cinnamon, among others.

GlucAffect becomes the sixth patented Reliv nutritional formula, joining Arthaffect® for joint health, Cellebrate® for weight loss, FibRestore® for digestive health, Innergize! ® for performance nutrition and ReversAge® for anti-aging nutrition.

View Reliv International Review

Related News

  • Reliv Unveils New LunaRich X Encapsulation Line
    CHESTERFIELD, MO, Apr 14, 2015 -- Reliv International, Inc. RELV, a maker of nutritional supplements that promote optimal health, today announced that the company has installed a new state-of-the-art encapsulation line at Reliv headquarters to manufacture LunaRich X(TM), a concentrated lunasin suppl...  Read More...
  • Reliv Honored with Two MarCom Awards
    November 10, 2014 -- Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced that the company has earned two 2014 MarCom Awards for outstanding achievement in marketing communications. Reliv's "How to Make Money with Reliv" video received a Platinum...  Read More...
  • Reliv Takes Top Distributors to Quebec City
    Annual Leadership Celebration Trip Honors Achievement in 2014CHESTERFIELD, MO , Sep 12, 2014 -- Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced that it has sent 67 Reliv Distributors on a four-day incentive trip to Quebec City. The Distri...  Read More...
  • Reliv Introduces New LunaRich Super Packs
    Chesterfield, MO March 31, 2014 -- Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced the launch of the LunaRich® Super Pack, a product package designed to facilitate new customer purchases and new distributor sign-ups. The launch took place th...  Read More...

 

Reliv International News Archive

New Companies on Npros

Receive News and
Updates from Npros.com

 Send me news updates
 Send me New Companies

RSS Npros News Feed